Physician
Pulmonology
Dr. Jenny T. Mao, MD
|
|
Give Review
Dr. Jenny T. Mao works in the field of Pulmonology. She studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. Dr. Jenny T. Mao is a published MD as well. She has 44 publications published. The latest was: Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.
Publications
- Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.
- Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
- Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1.
- Body mass index (BMI) change in adulthood and lung and upper aerodigestive tract (UADT) cancers.
- Lung cancer chemoprevention with celecoxib in former smokers.
- Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.
- The ninth annual american association of cancer research international conference on frontiers in cancer prevention research.
- Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.
- White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenases.
- Cancer and inflammation: promise for biologic therapy.
- Conference Report: Seventh Annual AACR International Conference on Frontiers in Cancer Prevention Research.
- Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers.
- Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.
- The partners--airflow obstruction, emphysema, and lung cancer.
- Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase.
- Differential modulation of leukotriene B4 synthesis and degradation in human bronchoalveolar lavage cells by lipopolysaccharide and tobacco smoke.
- Meeting report: Sixth Annual AACR International Conference on Frontiers in Cancer Prevention Research.
- Dietary flavonoid intake and lung cancer--a population-based case-control study.
- A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers.
- The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.
- TNF-alpha downregulates the leukotriene C4 synthase gene in mononuclear phagocytes.
- Celecoxib decreases Ki-67 proliferative index in active smokers.
- Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.
- Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.
- Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.
- Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.
- Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
- All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema.
- A pilot study of all-trans-retinoic acid for the treatment of human emphysema.
- Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis.
- Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline ...
- Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus.
- Oral iloprost improves endobronchial dysplasia in former smokers.
- Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.
- Eosinophil and T cell markers predict functional decline in COPD patients.
- Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers.
- Cyclooxygenase-2 in lung cancer.
- Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
- Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition).
- Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC.
- Feasibility of retinoids for the treatment of emphysema study.
- Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol.
- Multifaceted roles of cyclooxygenase-2 in lung cancer.
Schools
University of California At Los Angeles
UCLA Chs
Conditions Treated
- Sleep Apnea
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Education
-
UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Elizabeth E. Turner, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Carlos V. Haro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime Betancourt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary L. Zagelbaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank G. Buckle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramadas Abboy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Berj G. Demirjian, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher K. Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zea Borok, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rene Patino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jun D. Sasaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Babak B. Abrishami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhu S. Bajaj, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Navid Hakimian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua I. Santos, MD |
|
|
Dr. Talayeh Rezayat, DO
This Doctor is OpenDoctor Recommended.
|